The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans
Open accessAbstract
Significance: Vaccination is the most effective means of attaining protection against influenza viruses. However, the constantly evolving nature of influenza viruses enables them to escape preexisting immune surveillance, and thus thwarts public health efforts to control influenza annual epidemics and occasional pandemics. One solution is to elicit antibodies directed against highly conserved epitopes, such as those within the stem region of influenza HA, the principal target of virus-neutralizing antibody responses. This study shows that annual influenza vaccines induce antibody responses that are largely directed against the highly variable HA head region. In contrast, heterologous immunization with HA derived from influenza strains that are currently not circulating in humans (e.g. H5N1) can substantially increase HA stem-specific responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These data support the hypothesis that pre-existing immunity to influenza may improve the breadth of responses elicited by H5 HA vaccines.”
From Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge in mice (2025) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“the HA head is an immunodominant target of vaccine-induced immunity11”
From Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge in mice (2025) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“Humans with pre-existing influenza immunity vaccinated with an H5 vaccine developed greater broadly neutralizing antibody responses11, suggesting pre-existing immunity may improve the breadth of response to H5N1 vaccination.”
From Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge in mice (2025) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Receptor Binding and Membrane Fusion in Virus Entry: The Influenza Hemagglutinin
Skehel, J. J., & Wiley, D. C. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.531 · Cited by 2,706
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Ekiert, D. C., Bhabha, G., Elsliger, M.-A., Friesen, R. H. E., Jongeneelen, M., Throsby, M., Goudsmit, J., & Wilson, I. A. (2009) · Science · doi:10.1126/science.1171491 · Cited by 1,326
Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus
Hancock, K., Veguilla, V., Lu, X., Zhong, W., Butler, E. N., Sun, H., Liu, F., Dong, L., DeVos, J. R., Gargiullo, P. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906453 · Cited by 1,260
Humoral Immunity Due to Long-Lived Plasma Cells
Slifka, M. K., Antia, R., Whitmire, J. K., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80541-5 · Cited by 1,249
Self-citationCorti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A., Vanzetta, F., et al. (2011) · Science · doi:10.1126/science.1205669 · Cited by 1,203
Sui, J., Hwang, W. C., Perez, S., Ge, W., Aird, D. R., Chen, L., Santelli, E., Stec, B., Cadwell, G., Ali, M., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1566 · Cited by 1,128
The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype)
Caton, A. J., Brownlee, G. G., Yewdell, J. W., & Gerhard, W. (1982) · Cell · doi:10.1016/0092-8674(82)90135-0 · Cited by 1,036
Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
Wrammert, J., Smith, K., Miller, J., Langley, W. A., Kokko, K. E., Larsen, C. P., Zheng, N., Mays, I., Garman, L., Helms, C., et al. (2008) · Nature · doi:10.1038/nature06890 · Cited by 1,026
Self-citationHighly Conserved Protective Epitopes on Influenza B Viruses
Dreyfus, C., Laursen, N. S., Kwaks, T., Zuijdgeest, D., Khayat, R., Ekiert, D. C., Lee, J. H., Metlagel, Z., Bujny, M. V., Jongeneelen, M. A. C., et al. (2012) · Science · doi:10.1126/science.1222908 · Cited by 857
Wrammert, J., Koutsonanos, D., Li, G., Edupuganti, S., Sui, J., Michael, M., McCausland, M. M., Skountzou, I., Hornig, M., Lipkin, W. I., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101352 · Cited by 777
Self-citation
Cited by
Sorted by citations
Items 201–235 of 235
Hawman, D. W., Griffin, A., McCarthy, N., Okumura, A., Leventhal, S. S., Agumamidi, M., Chorabik, M., Altynova, E. S., Lewis, M. C., Hinkley, T. C., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adw4646 · Cited by 3
SARS-CoV-2: an unknown agent and challenges in vaccine development
Xu, J. (2020) · Journal of Bio-X Research · doi:10.1097/jbr.0000000000000063 · Cited by 2
Luke, C. J., Lakdawala, S. S., & Subbarao, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00032-8 · Cited by 3
Yegorov, S., Celeste, D. B., Gomes, K. B., Ang, J. C., Vandenhof, C., Wang, J., Rybkina, K., Tsui, V., Loeb, M. B., & Miller, M. S. (2021) · medRxiv · doi:10.1101/2021.08.03.21261495 · Cited by 2
Self-citationDesikan, R., Linderman, S. L., Davis, C. W., Zarnitsyna, V. I., Ahmed, H., & Antia, R. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.21.492928 · Cited by 2
Self-citationPebody, R. G., & Subbarao, K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00034-7 · Cited by 1
Phenomenological Modeling of Antibody Response from Vaccine Strain Composition
Ovchinnikov, V., & Karplus, M. (2025) · Antibodies · doi:10.3390/antib14010006 · Cited by 1
Ying, B., Pyles, K. D., Darling, T. L., Seehra, K., Pham, T., Huang, L.-C., Harastani, H., Sharma, A., Desai, P., Kashentseva, E. A., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102582 · Cited by 1
Wan, X., Guan, M., Balamalaliyage, P., Chen, H., Prasai, K., Alcala, A., Driver, J. P., Olivier, A. K., Gu, W., Frymire, C., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70202-y · Cited by 4
Influenza Virus Antigenic Drift: Balancing Fitness and Immune Evasion
Good, M. R., Lemus-Reyes, J. I., & Guthmiller, J. J. (2026) · Annual Review of Virology · doi:10.1146/annurev-virology-100424-103728 · Cited by 1
Zhao, X., Qin, K., Guo, J., Wang, D., Li, Z., Zhu, W., Liu, L., Wang, D., Shu, Y., & Zhou, J. (2015) · Protein & Cell · doi:10.1007/s13238-015-0160-6 · Cited by 1
CD8+ cytotoxic T lymphocytes in human influenza virus infection
Dong, T. (2015) · National Science Review · doi:10.1093/nsr/nwv033 · Cited by 1
1st Workshop of the Canadian Society for Virology
McCormick, C., & Grandvaux, N. (2017) · Viruses · doi:10.3390/v9030054 · Cited by 1
Vilela, L., Silva, A. G., Cruz, A. S., Sousa, M., Costa, M., Fonseca, F., Campino, S. G., Clark, T. G., & Miranda, A. (2024) · Vaccines · doi:10.3390/vaccines12121358 · Cited by 1
Highly mutated memory cells drive an inefficient secondary antibody response to a variant proteinPreprint
Tennant, R., Holzer, B., Love, J., Tchilian, E. Z., & White, H. N. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/438184 · Cited by 1
Wang, J., Li, D., Perry, S., Hilchey, S. P., Wiltse, A., Treanor, J. J., Sangster, M. Y., & Zand, M. S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.14.340448 · Cited by 1
Anderson, C., Sangster, M. Y., Yang, H., Chaudhury, S., & Topham, D. J. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/346726
Universal Vaccines against Influenza Viruses: Overview of the Past, Present, and Prospective
Agung, Y., Stacey, H. D., D’Agostino, M. R., & Zhang, A. (2020) · McMaster University Medical Journal · doi:10.15173/mumj.v17i1.2347
Pedrina, J., & Stambas, J. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.703456
Plant-Expressed Recombinant Universal Influenza A Vaccine Candidates
Favre, B. C. (2019) · Arizona State University Library Digital Repository (Arizona State University)
Influenza Virus and Vaccination
DeDiego, M. L., & Nogales, A. (2020) · MDPI eBooks · doi:10.3390/books978-3-03928-818-2 · Cited by 1
Wong, S., Lin, X., Wang, J., Ling, S., Xiao, C., Liang, Z., Bai, Y., Xiao, B., Yang, B., Cowling, B. J., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3234133/v1
Human cross-protective antibodies to occluded epitopes in influenza hemagglutinin antigen
Adachi, Y., Tonouchi, K., & Takahashi, Y. (2019) · Uirusu · doi:10.2222/jsv.69.161
Lin, X., Wang, J., Ling, S., Xiao, C., Liang, Z., Chow, C. L., Yang, B., Xiao, B., Cowling, B. J., Webby, R. J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.14.584765
Universal room-temperature stable influenza A nanovaccine
Siddoway, A. C. (2021) · doi:10.31274/td-20240329-849
Gonelli, C. A., Koutsakos, M., Esterbauer, R., Zheng, M. Z. M., Liu, Y., Zin, A., Schwab, L. S. U., Tilmanis, D., Aban, M., Hurt, A. C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.28.651131
Stolle, L., Bolton, J. S., Steventon, R., Gregory, R., Klim, H., Lee, M., Genova, C. D., Haddock, L., Bhatta, A., Carnell, G., et al. (2025) · medRxiv · doi:10.1101/2025.09.08.25335309
Oda, K., Danko, J., Villasante, E. F., Bergmann‐Leitner, E. S., Lee, R. J. Y., & Wijayalath, W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1663763
Guo, Z., Rowe, T., Chang, J. C., Carney, P. J., Steel, J., & Stevens, J. (2025) · npj Vaccines · doi:10.1038/s41541-025-01282-y
Quintero-Barbosa, J. S., Song, Y., Mehl, F., Mathur, S., Livingston, L., Shen, X., Montefiori, D. C., & Zeichner, S. L. (2026) · Viruses · doi:10.3390/v18080890
Ovchinnikov, V., & Karplus, M. (2026) · Antibodies · doi:10.3390/antib15040064
Allen, J. D., Medina, J. M., Caetano, C. C. D. S., Thomas, M. H., Lynch, A., & Ross, T. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.04.749505
Nazari, M., & Mehrazar, M. M. (2026) · Veterinary and Animal Science · doi:10.1016/j.vas.2026.100883
Pre-existing cross-subtype serological responses against H5Nx in health care workers
Dionne, K., Bélanger, É., Benlarbi, M., Beaudoin-Bussières, G., Saenz, C. S., Ding, S., Bourassa, C., Medjahed, H., Jennings, M., Laroche, G., et al. (2026) · Journal of Virology · doi:10.1128/jvi.01310-26
Metadata
- Authors
- Ellebedy, A. H., Krammer, F., Li, G.-M., Miller, M. S., Chiu, C., Wrammert, J., Chang, C. Y., Davis, C. W., McCausland, M., Elbein, R., Edupuganti, S., Spearman, P., Andrews, S. F., Wilson, P. C., García-Sastre, A., Mulligan, M. J., Mehta, A. K., Palese, P., & Ahmed, R.
- Affiliations
- Emory University (US)
- Department of Microbiology,
- Department of Microbiology and Immunology,
- Division of Infectious Diseases, Department of Medicine,
- Department of Pediatrics,
- University of Chicago (US)
- HOPE Clinic (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2014-08-25
- Volume
- 111
- Issue
- 36
- Pages
- 13133-13138
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4246941
- OpenAlex
- W1993577147
- Cited by
- 234
- References
- 42
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 12 · 2023: 8 · 2022: 13 · 2021: 24 · 2020: 24 · 2019: 24 · 2018: 30 · 2017: 21 · 2016: 21 · 2015: 19 · 2014: 1
- FWCI
- 15.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Georgia Research Alliance
- Children's Healthcare of Atlanta
- National Institute for Health and Care Research (NF-SI-0513-10150)
- Austrian Science Fund (J 3232)
- National Institutes of Health (HHSN272200800005C, UL1TR000454, P51OD011132)
- U.S. Public Health Service (HHSN26620070010C)
- Canadian Institutes of Health Research
- Medical Research Council (MC_G1001212)
- National Institute of Allergy and Infectious Diseases (U19AI109946, P01AI097092, HHSN266200700006C, HHSN26620070010C, HHSN272200800005C, U19AI082724, T32AI074492)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- influenza virus, broadly neutralizing antibodies, seasonal influenza vaccination, memory B cells, cross-reactive antibody response, conserved epitopes, heterologous immunization, pandemic influenza preparedness, B cell response
- MeSH terms
- Adult, Antibody Formation, Antibody Specificity, Cross Reactions, Humans, Immunoglobulin G, Immunologic Memory, Influenza, Human, Influenza Vaccines, Plasma Cells, Vaccination, Hemagglutinin Glycoproteins, Influenza Virus, Influenza A Virus, H5N1 Subtype
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
